Semaglutide Research Overview Semaglutide is a synthetic version of GLP-1, which plays a key role in regulating blood sugar levels and appetite
Regular monitoring includes HbA1c assessment every 3-6 months, renal function monitoring (particularly if gastrointestinal symptoms cause dehydration), and lipid profile assessment
The following is the PR that gave me the inspiration to write this piece: To view or add a comment, sign in 1,690 followers
[14] In patients with diabetes, overly aggressive glycemic control or inadequate adjustment of concurrent diabetes medications (particularly insulin or sulfonylureas) may result in hypoglycemia or relative hypoglycemia, even if glucose values remain within normal range
While GLP-1s have proven life-changing for people with diabetes, obesity, and other medical conditions, using them for cosmetic weight loss has always seemed a little extreme to me, at least for noncelebrities whose very income doesnt hinge on fitting societys expectations of what a person should look like
The peptide upregulates VEGF expression in multiple cell types and enhances endothelial cell responses to VEGF signaling